Bioline Rx (YP2.F) Q1 2025 Earnings

31MarConfirmed
Q4 2024
Q1 2025
-0
-0
-0
0

Details

Expected EPS
-0.00124412126
Actual EPS
-0.00246513477
Surprise EPS
-0
Surprise Percent
+98.14%

Description

Bioline Rx (YP2.F) has reported earnings of -0.00246513477 per share for Q1 2025.

0 Comments

Share your thoughts